Skip to main content

Table 2 Medical information of participants

From: The meaning of trust along the treatment pathway of women with breast cancer: a mixed-methods study among cancer survivors

Woman a

Treatment phases

UICC

-stage b

Grading

HER2 c

PR/ ER d

Ablatio

Age

Duration of study

Eve

Diagnosis; Surgery; Adj. radiation e; Follow up

IA

G2

missing value

missing value

no

48

8 months

Faith

Diagnosis; Surgery; Adj. ctx f; Adj. radiation e; Follow up

IIIA

G2

negative

positive

yes

54

11 months

Grace

Diagnosis; Neo adj. ctx g; Surgery; Adj. ctx f; Adj. radiation e; Follow up

IIIC

G3

negative

negative

no

46

16 months

Holly

Diagnosis; Surgery; Adj. ctx f; Adj. radiation e; Follow up

IA

G3

negative

positive

no

58

10 months

Katie

Diagnosis; Neo adj. ctx g; Surgery; Adj. radiation e; Follow up

IIA

G2

positive

positive

no

61

14 months

Laura

Diagnosis; Neo adj. ctx g; Surgery; Follow up

IIA

G3

positive

missing value

no

27

10 months

Mary

Diagnosis; Surgery; Adj. radiation e; Follow up

0 h

G3

missing value

negative

no

66

5 months

Norma

Diagnosis; Surgery; Adj. ctx f; Adj. radiation e; Follow up

IA

G3

positive

negative

no

36

11 months

Polly

Diagnosis; Neo adj. ctx g; Surgery; Adj. ctx e; Follow up

IIIC

GX

positive

positive

yes

40

11 months

Quincy

Diagnosis; Neo adj. ctx g; Surgery; Adj. ctx f; Follow up

IIA

G3

negative

positive

no

49

12 months

Rose

Diagnosis; Neo adj. ctx g; Surgery; Adj. ctx e; Follow up

IIB

G2

positive

positive

yes

58

16 months

Sarah

Diagnosis; Surgery; Adj. ctx f; Follow up

IA

G1

negative

positive

no

54

2 months

  1. a names are pseudonyms; b Union for International Cancer Control; c human epidermal growth factor receptor; d progesterone receptors/estrogen receptors; e adjuvant radiation therapy; f adjuvant chemotherapy; g neoadjuvant chemotherapy; h multifocal ductal carcinoma in situ